Dr. Anne Moore

Professor Anne Moore holds a joint position between the School of Biochemistry and Cell Biology, UCC, and the National Institute of Bioprocessing Research and Training (NIBRT). She completed a PhD in HIV vaccine immunology with Professor Kingston Mills and subsequently embarked upon post-doctoral work on defects in immune responses in HIV-infected individuals in the Wistar Institute in Philadelphia and further work on vaccines against viruses such as HIV and Ebola virus in Dr. Gary Nabel’s lab, then at the University of Michigan. As a senior immunologist in Prof. Adrian Hill’s group at the University of Oxford, she developed several vaccine candidates against malaria, TB, and the influenza virus. In UCC, Prof. Anne Moore moved from a lectureship in Pharmacology, based in the School of Pharmacy, UCC, to a senior lectureship in Biochemistry in 2018. She has won several awards, including leading the UCC Research Team of the Year in UCC in 2012. Prof. Anne Moore’s research focus is to enhance vaccine accessibility and acceptability. She and her research group use vaccine development strategies and qualitative research methodologies to advance these research aims.